Pasteurella multocida vaccine
AssigneeWim de Korverstraat 35
InventorYugang Luo
Life of this patent
Estimating the term…
Abstract
The present invention relates to live attenuated bacteria of the species Pasteurella multocida, to live attenuated vaccines comprising such live attenuated bacteria, to the use of such bacteria for the manufacture of such vaccines, to methods for the preparation of such vaccines and to diagnostic tests for the detection of such bacteria.
Claims15
A live attenuated Pasteurella multocida bacterium, said bacterium not being capable to-express of expressing a functional Orf-15 protein.
The live attenuated bacterium according to claim 42 wherein said one or more antigens are selected from the group consisting of Fowlpox virus, Infectious Bronchitis virus, Infectious Bursal Disease, Marek's Disease Virus, Chicken Anaemia agent, Avian Reovirus, Mycoplasma gallisepticum, Turkey Rhinotracheitis virus, Haemophilus paragallinarum, Chicken Poxvirus, Avian Encephalomyelitisvirus, Duck Plague virus, Newcastle Disease virus, Egg Drop syndrome virus, Infectious Laryngotracheitis virus, Herpes Virus of Turkeys, Eimeria species, Ornithobacterium rhinotracheale, Mycoplasma synoviae, Clostridium perfringens, Salmonella species and E. coll.
13-16. (canceled)
A diagnostic test for the detection of Pasteurella multocida associated DNA or RNA, wherein the test comprises a nucleic acid molecule as depicted in SEQ ID NO:
- 1 or a nucleic acid molecule that is complementary to said nucleic acid sequence, or a fragment thereof having a length of at least 12 nucleotides.
Dependencies are inferred from the claim text.